AUD 0.63
(-8.03%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | -20.33 Million AUD | -54.8% |
2023 | -13.13 Million AUD | -478.9% |
2022 | 4.69 Million AUD | 53.69% |
2021 | 3.21 Million AUD | 175.55% |
2020 | -1.69 Million AUD | -26.18% |
2019 | -3.12 Million AUD | -13.07% |
2018 | -2.76 Million AUD | -20.05% |
2017 | -2.3 Million AUD | 11.32% |
2016 | -2.59 Million AUD | -5.93% |
2015 | -2.37 Million AUD | -116.9% |
2014 | -2.23 Million AUD | 48.71% |
2013 | -2.2 Million AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 FY | - AUD | -16.45% |
2024 Q2 | -11.31 Million AUD | 0.0% |
2024 Q4 | -9.01 Million AUD | 0.0% |
2023 Q4 | -11.47 Million AUD | 0.0% |
2023 FY | - AUD | -478.9% |
2023 Q2 | -6.01 Million AUD | 0.0% |
2022 Q4 | -889 Thousand AUD | 0.0% |
2022 FY | - AUD | 53.69% |
2022 Q2 | 5.45 Million AUD | 0.0% |
2021 FY | - AUD | 175.55% |
2021 Q4 | -2.04 Million AUD | 0.0% |
2021 Q2 | 4.93 Million AUD | 0.0% |
2020 Q2 | -3.12 Million AUD | 0.0% |
2020 FY | - AUD | -26.18% |
2020 Q4 | -957 Thousand AUD | 0.0% |
2019 Q4 | -2.61 Million AUD | 0.0% |
2019 Q2 | -1.52 Million AUD | 0.0% |
2019 FY | - AUD | -13.07% |
2018 Q4 | -1.36 Million AUD | 0.0% |
2018 Q2 | -1.39 Million AUD | 0.0% |
2018 FY | - AUD | -20.05% |
2017 Q2 | -1.11 Million AUD | 0.0% |
2017 FY | - AUD | 11.32% |
2017 Q4 | -1.19 Million AUD | 0.0% |
2016 Q2 | -1.42 Million AUD | 0.0% |
2016 Q4 | -1.17 Million AUD | 0.0% |
2016 FY | - AUD | -5.93% |
2015 Q2 | -1.25 Million AUD | 0.0% |
2015 Q4 | -1.12 Million AUD | -83.47% |
2015 FY | - AUD | -116.9% |
2015 Q3 | -613.27 Thousand AUD | 51.12% |
2015 Q1 | - AUD | 0.0% |
2014 FY | - AUD | 48.71% |
2014 Q2 | - AUD | 0.0% |
2014 Q3 | - AUD | 0.0% |
2014 Q4 | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Australian Clinical Labs Limited | 181.83 Million AUD | 111.185% |
BCAL Diagnostics Limited | -5.66 Million AUD | -258.897% |
Genetic Technologies Limited | -11.43 Million AUD | -77.924% |
Healius Limited | -298.09 Million AUD | 93.177% |
Imagion Biosystems Limited | -13.69 Million AUD | -48.487% |
Integral Diagnostics Limited | 12.33 Million AUD | 264.894% |
INOVIQ Ltd | -6.63 Million AUD | -206.601% |
Microba Life Sciences Limited | -22.8 Million AUD | 10.833% |
Monash IVF Group Limited | 13.02 Million AUD | 256.146% |
Rhythm Biosciences Limited | -6.79 Million AUD | -199.269% |
Sonic Healthcare Limited | 1.65 Billion AUD | 101.226% |